Electrophysiological evidence for heterogeneity of lesions in optic neuritis.
暂无分享,去创建一个
Alexander Klistorner | Michael Paine | Stuart Graham | Clare Fraser | S. Graham | H. Arvind | J. Grigg | A. Klistorner | C. Fraser | R. Garrick | F. Billson | J. O'day | Tan-Trung Nguyen | M. Paine | Raymond Garrick | John Grigg | Hemamalini Arvind | Justin O'Day | Tan Nguyen | Frank A Billson
[1] S. Klein,et al. The topography of visual evoked response properties across the visual field. , 1994, Electroencephalography and clinical neurophysiology.
[2] L. Kurland,et al. Optic neuritis , 1995, Neurology.
[3] S. Ludwin,et al. Evidence for a “dying‐back” gliopathy in demyelinating disease , 1981, Annals of neurology.
[4] M. Rodriguez. Virus-induced demyelination in mice: "dying back" of oligodendrocytes. , 1985, Mayo Clinic proceedings.
[5] P. Shrager,et al. 8 – Na+ Channel Reorganization in Demyelinated Axons , 2005 .
[6] C. Dijkstra,et al. Induction of nitric oxide synthase in multiple sclerosis lesions , 1997 .
[7] R. Hidajat,et al. Normalisation of visual evoked potentials after optic neuritis , 2003, Documenta Ophthalmologica.
[8] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[9] H. Lassmann,et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.
[10] S L Graham,et al. Objective VEP Perimetry in Glaucoma: Asymmetry Analysis to Identify Early Deficits , 2000, Journal of glaucoma.
[11] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[12] S. Waxman,et al. The Conduction Properties of Demyelinated and Remyelinated Axons , 2005 .
[13] T A Sears,et al. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. , 1978, The Journal of physiology.
[14] B E Kendall,et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.
[15] Nitin Ohri,et al. Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. , 2004, Investigative ophthalmology & visual science.
[16] Ivan Goldberg,et al. Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice. , 2005, Archives of ophthalmology.
[17] J. Frederiksen,et al. Serial visual evoked potentials in 90 untreated patients with acute optic neuritis. , 1999, Survey of ophthalmology.
[18] S. Graham,et al. Multifocal topographic visual evoked potential: improving objective detection of local visual field defects. , 1998, Investigative ophthalmology & visual science.
[19] R. Foster,et al. Reorganization of the axon membrane in demyelinated peripheral nerve fibers: morphological evidence. , 1980, Science.
[20] W. Mcdonald,et al. The restoration of conduction by central remyelination. , 1981, Brain : a journal of neurology.
[21] W. I. McDonald,et al. Spontaneous and evoked electrical discharges from a central demyelinating lesion , 1982, Journal of the Neurological Sciences.
[22] D. Chari,et al. Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.
[23] Alastair Compston,et al. McAlpine's Multiple Sclerosis , 2005 .
[24] S L Graham,et al. The diagnostic significance of the multifocal pattern visual evoked potential in glaucoma. , 1999, Current opinion in ophthalmology.
[25] P M Matthews,et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.
[26] K. Frei,et al. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis , 1998, European journal of immunology.
[27] V. Torri,et al. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests , 1999, Journal of Neurology.
[28] C. Raine,et al. Multiple Sclerosis: Remyelination in Acute Lesions , 1993, Journal of neuropathology and experimental neurology.
[29] B. Scheithauer,et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.
[30] S. Graham,et al. Objective perimetry in glaucoma. , 2000, Ophthalmology.
[31] Alexander Klistorner,et al. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis. , 2006, Archives of neurology.
[32] Rasa Ruseckaite,et al. Sparse multifocal stimuli for the detection of multiple sclerosis , 2005, Annals of neurology.
[33] M. Barnett,et al. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.
[34] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[35] S. Graham,et al. Multifocal objective perimetry in the detection of glaucomatous field loss. , 2002, American journal of ophthalmology.
[36] G. Ebers,et al. Optic Neuritis and Multiple Sclerosis , 1983, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[37] A. Thompson,et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.
[38] W. Mcdonald,et al. The pathophysiology of multiple sclerosis , 2006 .
[39] Michael Wall,et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.
[40] Chris A. Johnson,et al. Determining abnormal latencies of multifocal visual evoked potentials: a monocular analysis , 2004, Documenta Ophthalmologica.
[41] D. Hood,et al. Tracking the recovery of local optic nerve function after optic neuritis: a multifocal VEP study. , 2000, Investigative ophthalmology & visual science.
[42] W. Mcdonald,et al. Delayed visual evoked response in optic neuritis. , 1972, Lancet.
[43] Moses Rodriguez. Virus-induced demyelination in mice , 1985 .
[44] Stephen J. Jones,et al. Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. , 2001, Brain : a journal of neurology.
[45] Gordon T. Plant,et al. Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials , 1999, Journal of Neurology.
[46] C. Lucchinetti,et al. Remyelination in multiple sclerosis , 1997, Multiple sclerosis.
[47] S. Graham,et al. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis. , 2006, Ophthalmology.
[48] S G Waxman,et al. Multiple sclerosis as a neuronal disease. , 2005, Archives of neurology.
[49] D. Hood,et al. Improvement in conduction velocity after optic neuritis measured with the multifocal VEP. , 2007, Investigative ophthalmology & visual science.
[50] J. Parisi,et al. The pathology of multiple sclerosis: evidence for heterogeneity. , 2006, Advances in neurology.
[51] S L Graham,et al. Electroencephalogram-based scaling of multifocal visual evoked potentials: effect on intersubject amplitude variability. , 2001, Investigative ophthalmology & visual science.
[52] T A Sears,et al. The effects of experimental demyelination on conduction in the central nervous system. , 1970, Brain : a journal of neurology.
[53] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[54] H. Lassmann,et al. Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology , 1998, Brain pathology.
[55] Steve J Jones,et al. Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection , 2003, Journal of the Neurological Sciences.
[56] Michael Wall,et al. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group , 2002, Neurology.